U.S., Nov. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07223242) titled 'Tailored Exercise Training Study Among Adults With HFpEF' on Oct. 06.
Brief Summary: Heart failure with preserved ejection fraction (HFpEF) is associated with a high morbidity and mortality burden. There are limited pharmacological options available for the treatment of HFpEF. Exercise intolerance (EI) is the cardinal symptom of HFpEF, which manifests as dyspnea and fatigue. EI leads to functional deconditioning and reduced quality of life (QOL), both of which elevate risk of death and hospitalization in patients with HFpEF. Supervised exercised training is associated with improvements in exercise capacity and QOL in adults with HFpE...